Nektar Therapeutics (NKTR)
1.38
+0.01
(+0.73%)
USD |
NASDAQ |
Jul 26, 16:00
1.38
0.00 (0.00%)
After-Hours: 20:00
Nektar Therapeutics Price: 1.38 for July 26, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 25, 2024 | 1.43 | 1.43 | 1.325 | 1.37 | 1.046M |
| Jul 24, 2024 | 1.47 | 1.50 | 1.39 | 1.41 | 942828.0 |
| Jul 23, 2024 | 1.45 | 1.50 | 1.43 | 1.48 | 724967.0 |
| Jul 22, 2024 | 1.39 | 1.49 | 1.38 | 1.46 | 1.270M |
| Jul 19, 2024 | 1.36 | 1.435 | 1.301 | 1.39 | 1.051M |
| Jul 18, 2024 | 1.45 | 1.47 | 1.32 | 1.35 | 807326.0 |
| Jul 17, 2024 | 1.43 | 1.520 | 1.40 | 1.45 | 1.696M |
| Jul 16, 2024 | 1.43 | 1.50 | 1.400 | 1.47 | 1.351M |
| Jul 15, 2024 | 1.45 | 1.46 | 1.34 | 1.40 | 1.865M |
| Jul 12, 2024 | 1.35 | 1.46 | 1.320 | 1.42 | 2.213M |
| Jul 11, 2024 | 1.35 | 1.42 | 1.32 | 1.36 | 1.915M |
| Jul 10, 2024 | 1.24 | 1.33 | 1.21 | 1.33 | 1.600M |
| Jul 09, 2024 | 1.22 | 1.265 | 1.20 | 1.23 | 1.119M |
| Jul 08, 2024 | 1.28 | 1.34 | 1.22 | 1.24 | 1.415M |
| Jul 05, 2024 | 1.31 | 1.335 | 1.18 | 1.29 | 2.301M |
| Jul 03, 2024 | 1.17 | 1.33 | 1.17 | 1.30 | 1.446M |
| Jul 02, 2024 | 1.20 | 1.25 | 1.10 | 1.17 | 1.433M |
| Jul 01, 2024 | 1.25 | 1.31 | 1.13 | 1.22 | 2.354M |
| Jun 28, 2024 | 1.16 | 1.30 | 1.120 | 1.24 | 25.17M |
| Jun 27, 2024 | 1.09 | 1.19 | 1.07 | 1.14 | 2.124M |
| Jun 26, 2024 | 1.05 | 1.12 | 1.01 | 1.085 | 1.708M |
| Jun 25, 2024 | 1.16 | 1.16 | 1.06 | 1.07 | 1.781M |
| Jun 24, 2024 | 1.12 | 1.24 | 1.09 | 1.17 | 2.201M |
| Jun 21, 2024 | 1.08 | 1.17 | 1.04 | 1.16 | 2.581M |
| Jun 20, 2024 | 1.14 | 1.19 | 1.06 | 1.09 | 1.274M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.4227
Minimum
Nov 28 2023
31.19
Maximum
Aug 01 2019
10.58
Average
11.15
Median
Price Benchmarks
| Assertio Holdings Inc | 1.505 |
| Ligand Pharmaceuticals Inc | 107.08 |
| Verastem Inc | 2.955 |
| Cara Therapeutics Inc | 0.375 |
| Ocugen Inc | 1.63 |
Price Related Metrics
| PS Ratio | 2.930 |
| Price to Book Value | 2.000 |
| Earnings Yield | -66.67% |
| Market Cap | 253.40M |